Verified peer comparison
SCHMID Group vs AgomAb Therapeutics Financial Comparison
Direct answer
SCHMID Group and AgomAb Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in EUR.
Common metrics include Revenue, Operating income, Net income.
Alpha Vantage
Get free SCHMID Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- SCHMID Group Revenue
- 64,302,860 EUR
- AgomAb Therapeutics Revenue
- 0 EUR
- SCHMID Group Operating income
- -9,908,855 EUR
- AgomAb Therapeutics Operating income
- -59,275,000 EUR